Key Messages from KDIGO IgAN Experts (2025)
These videos are part of a three-part series featuring IgA Nephropathy (IgAN) experts and Work Group Members of the forthcoming KDIGO 2025 IgAN Guideline Update sharing key insights on emerging topics in IgAN, including diagnostic strategies, changes in disease management, evolving therapies, and challenges across special populations. These short videos offer a valuable preview of what to expect in the updated KDIGO IgAN Guideline and how global nephrology practice is evolving to improve outcomes for patients with IgAN.
KDIGO 2025 IgAN Guideline Key Messages and Implications — Dr. Hernán Trimarchi
In this video, Dr. Hernán Trimarchi highlights some of the most significant developments included in the draft KDIGO 2025 IgAN Guideline, including the importance of early detection and kidney biopsy, the introduction of the IgAN risk prediction tool, and a more proactive, individualized approach to treatment. He discusses how these changes represent a shift in mindset—away from solely managing consequences and toward targeting the disease itself—and reflects on the challenges and opportunities for implementation, especially in low- and middle-income countries.
References:
- The KDIGO 2025 IgAN Guideline is expected to be published in October 2025. Learn more: IgA Nephropathy (IgAN) / IgA Vasculitis (IgAV) – KDIGO (Accessed 5/1/2025)
Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.
July 2025 US.CORP.V.25.00032 / US.CORP.V.25.00033/ US.CORP.V.25.00034/ US.CORP.X.25.00098